American Well (NYSE:AMWL) Price Target Raised to $10.00 at Stifel Nicolaus

American Well (NYSE:AMWL) had its price target hoisted by Stifel Nicolaus from $9.00 to $10.00 in a research report released on Thursday,Benzinga reports. Stifel Nicolaus currently has a hold rating on the stock.

A number of other equities analysts also recently weighed in on the stock. Needham & Company LLC reaffirmed a “hold” rating on shares of American Well in a research note on Thursday. Morgan Stanley dropped their price objective on shares of American Well from $20.00 to $10.50 and set an “equal weight” rating for the company in a research report on Tuesday, December 17th. Finally, Wells Fargo & Company raised American Well from an “equal weight” rating to an “overweight” rating and set a $15.00 price objective on the stock in a report on Monday, January 13th. Four analysts have rated the stock with a hold rating and one has assigned a buy rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Hold” and an average target price of $11.88.

American Well Stock Down 5.1 %

NYSE AMWL opened at $11.73 on Thursday. The stock has a market cap of $179.63 million, a P/E ratio of -0.80 and a beta of 1.18. American Well has a twelve month low of $5.00 and a twelve month high of $29.00. The company’s 50-day simple moving average is $9.21 and its 200 day simple moving average is $9.12.

American Well (NYSE:AMWL) last released its quarterly earnings data on Wednesday, February 12th. The company reported ($2.77) earnings per share for the quarter, beating the consensus estimate of ($3.04) by $0.27. American Well had a negative return on equity of 52.49% and a negative net margin of 84.27%. Research analysts anticipate that American Well will post -13.38 earnings per share for the current year.

Institutional Investors Weigh In On American Well

Several institutional investors have recently modified their holdings of AMWL. Cubist Systematic Strategies LLC boosted its position in shares of American Well by 7,673.8% in the 2nd quarter. Cubist Systematic Strategies LLC now owns 184,083 shares of the company’s stock worth $60,000 after purchasing an additional 181,715 shares during the last quarter. BNP Paribas Financial Markets acquired a new position in American Well in the third quarter valued at about $95,000. Walleye Capital LLC bought a new position in American Well during the third quarter worth about $167,000. PDT Partners LLC acquired a new position in shares of American Well during the 3rd quarter worth about $107,000. Finally, HighTower Advisors LLC bought a new stake in shares of American Well in the 3rd quarter valued at about $355,000. Institutional investors and hedge funds own 56.05% of the company’s stock.

American Well Company Profile

American Well Corporation, an enterprise platform and software company, delivers digitally enabling hybrid care in the United States and internationally. The company offers Converge, a cloud-based platform that enables health providers, payers, and innovators to provide in-person, virtual and automated care; and delivers virtual primary care, post-discharge follow-up, chronic condition management, virtual nursing, e-sitting, on-demand and scheduled virtual visits, specialty consults, automated care, and behavioral health, as well as specialty care programs, including dermatology, musculoskeletal care, second opinion, and cardiometabolic care to patients and members.